• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较镓-前列腺特异性膜抗原PET/CT与多参数MRI在局部晚期前列腺癌盆腔淋巴结转移中的诊断价值。

Comparing the diagnostic value of Ga-prostate-specific membrane antigen PET/CT and multiparametric MRI in pelvic lymph node metastasis of locally advanced prostate cancer.

作者信息

Xiong Zezhong, Ge Yue, Ma Sheng, Wang Yanan, Li Le, Chao Zheng, Wang Xia, Sulaiman Manan, Li Cong, Luan Yang, Yang Chunguang, Zeng Xing, Yu Gan, Zou Sijuan, Zhu Xiaohua, Wang Shaogang, Hu Zhiquan, Yang Qin, Qin Baolong, Wang Zhihua

机构信息

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Transl Androl Urol. 2024 Jul 31;13(7):1219-1227. doi: 10.21037/tau-24-15. Epub 2024 Jul 3.

DOI:10.21037/tau-24-15
PMID:39100834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11291416/
Abstract

BACKGROUND

Multiparametric magnetic resonance imaging (mpMRI) is a commonly used method to diagnose pelvic lymph node metastasis (PLNM) in prostate cancer (PCa) patients, but there are few comparative studies on mpMRI and Ga-prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) in locally advanced PCa (LAPC) patients. Therefore, we designed a retrospective study to compare the diagnostic value of Ga-PSMA PET/CT and mpMRI for PLNM of LAPC.

METHODS

A retrospective study was performed on 50 patients with LAPC who underwent radical prostatectomy (RP) in Tongji Hospital from 2021 to 2023. All patients underwent PET/CT and mpMRI examination, and were diagnosed as LAPC before surgery, followed by robot-assisted laparoscopic prostatectomy or laparoscopic RP and extended pelvic lymph node dissection (ePLND). Routine postoperative pathological examination was performed. According to the results, the sensitivity, specificity, positive predictive value, and negative predictive value of Ga-PSMA PET/CT and mpMRI for the diagnosis of PLNM of LAPC were compared.

RESULTS

Among the 50 patients, the mean age was 65.5±10.3 years, the preoperative total serum prostate-specific antigen (PSA) was 30.7±12.3 ng/mL, and the Gleason score was 7 [7, 8]. The difference in diagnostic efficacy between Ga-PSMA PET/CT and mpMRI in the preoperative diagnosis of PLNM of PCa was determined by postoperative pathological results. Based on the number of patients who developed PLNM, the sensitivity, specificity, positive predictive value, and negative predictive value of Ga-PSMA PET/CT were as follows: 93.75%, 100.00%, 100.00%, 97.14%, and 68.75%, 97.06%, 91.67%, 86.84% for mpMRI, respectively. Based on the number of pelvic metastatic lymph nodes, the sensitivity, specificity, positive predictive value, and negative predictive value of Ga-PSMA PET/CT were 95.24%, 100.00%, 100.00%, 99.48%, and 65.08%, 99.13%, 89.13%, 96.30% for mpMRI, respectively. It turned out that PET/CT was more sensitive than mpMRI in detecting PLNM of PCa, and the difference was statistically significant.

CONCLUSIONS

Ga-PSMA PET/CT is more sensitive than mpMRI in the detection of PLNM in patients with LAPC. It is a promising method in the diagnosis and preoperative assessment of PLNM in LAPC.

摘要

背景

多参数磁共振成像(mpMRI)是诊断前列腺癌(PCa)患者盆腔淋巴结转移(PLNM)的常用方法,但在局部晚期PCa(LAPC)患者中,关于mpMRI与镓-前列腺特异性膜抗原(PSMA)正电子发射断层扫描(PET)/计算机断层扫描(CT)的比较研究较少。因此,我们设计了一项回顾性研究,比较镓-PSMA PET/CT和mpMRI对LAPC患者PLNM的诊断价值。

方法

对2021年至2023年在同济医院接受根治性前列腺切除术(RP)的50例LAPC患者进行回顾性研究。所有患者均接受PET/CT和mpMRI检查,术前被诊断为LAPC,随后接受机器人辅助腹腔镜前列腺切除术或腹腔镜RP及扩大盆腔淋巴结清扫术(ePLND)。术后进行常规病理检查。根据结果,比较镓-PSMA PET/CT和mpMRI对LAPC患者PLNM诊断的敏感性、特异性、阳性预测值和阴性预测值。

结果

50例患者中,平均年龄为65.5±10.3岁,术前血清总前列腺特异性抗原(PSA)为30.7±12.3 ng/mL,Gleason评分7分[7, 8]。PCa患者术前PLNM诊断中镓-PSMA PET/CT与mpMRI诊断效能的差异由术后病理结果确定。根据发生PLNM的患者数量,镓-PSMA PET/CT的敏感性、特异性、阳性预测值和阴性预测值分别为:93.75%、100.00%、100.00%、97.14%,mpMRI分别为68.75%、97.06%、91.67%、86.84%。根据盆腔转移淋巴结数量,镓-PSMA PET/CT的敏感性、特异性、阳性预测值和阴性预测值分别为95.24%、100.00%、100.00%、99.48%,mpMRI分别为65.08%、99.13%、89.13%、96.30%。结果表明,PET/CT在检测PCa患者PLNM方面比mpMRI更敏感,差异有统计学意义。

结论

镓-PSMA PET/CT在检测LAPC患者PLNM方面比mpMRI更敏感。它是LAPC患者PLNM诊断和术前评估中有前景的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2a/11291416/b8dd492b78a8/tau-13-07-1219-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2a/11291416/b8dd492b78a8/tau-13-07-1219-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2a/11291416/b8dd492b78a8/tau-13-07-1219-f1.jpg

相似文献

1
Comparing the diagnostic value of Ga-prostate-specific membrane antigen PET/CT and multiparametric MRI in pelvic lymph node metastasis of locally advanced prostate cancer.比较镓-前列腺特异性膜抗原PET/CT与多参数MRI在局部晚期前列腺癌盆腔淋巴结转移中的诊断价值。
Transl Androl Urol. 2024 Jul 31;13(7):1219-1227. doi: 10.21037/tau-24-15. Epub 2024 Jul 3.
2
Histological comparison between predictive value of preoperative 3-T multiparametric MRI and Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.术前 3-T 多参数 MRI 和 Ga-PSMA PET/CT 扫描对前列腺癌根治性前列腺切除术和盆腔淋巴结清扫术病理结果的预测价值的组织学比较。
BJU Int. 2021 Jan;127(1):71-79. doi: 10.1111/bju.15134. Epub 2020 Sep 7.
3
Incremental Impact of [ Ga]Ga-PSMA-11 PET/CT in Primary N and M Staging of Prostate Cancer Prior to Curative-Intent Surgery: a Prospective Clinical Trial in Comparison with mpMRI.[68Ga]Ga-PSMA-11 PET/CT 对前列腺癌根治性手术前 N 和 M 分期的增量影响:与 mpMRI 比较的前瞻性临床试验。
Mol Imaging Biol. 2022 Feb;24(1):50-59. doi: 10.1007/s11307-021-01650-9. Epub 2021 Sep 14.
4
Comparison of Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer.镓-PSMA-11 PET-CT 与 mpMRI 用于中高危前列腺癌患者术前淋巴结分期的比较。
J Transl Med. 2017 Nov 7;15(1):230. doi: 10.1186/s12967-017-1333-2.
5
Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen ( Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection.根治性前列腺切除术后加病理阳性淋巴结清扫术,前列腺特异性膜抗原(Ga-PSMA)正电子发射/计算机断层扫描后前列腺癌复发的分布。
BJU Int. 2020 Jun;125(6):876-883. doi: 10.1111/bju.15052. Epub 2020 Apr 23.
6
Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL).氟-18 标记的前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描或磁共振成像用于诊断和定位前列腺癌。一项前瞻性单臂配对比较(PEDAL)。
Eur Urol Oncol. 2024 Oct;7(5):1015-1023. doi: 10.1016/j.euo.2024.01.002. Epub 2024 Jan 27.
7
The diagnostic accuracy of Ga-PSMA-PET/CT in primary staging of patients with high-risk nonmetastatic prostate cancer treated with radical prostatectomy: A single-center cohort analysis.镓-PSMA-PET/CT 在接受根治性前列腺切除术治疗的高危局限性前列腺癌患者初始分期中的诊断准确性:一项单中心队列分析。
Prostate. 2024 Jan;84(1):74-78. doi: 10.1002/pros.24627. Epub 2023 Sep 26.
8
A comparison study of 68gallium-prostate-specific membrane antigen positron emission tomography-computed tomography and multiparametric magnetic resonance imaging for locoregional staging of prostate cancer.68镓-前列腺特异性膜抗原正电子发射断层扫描-计算机断层扫描与多参数磁共振成像用于前列腺癌局部区域分期的比较研究
Urol Sci. 2024 Mar;35(1):36-41. doi: 10.1097/us9.0000000000000002. Epub 2024 Mar 29.
9
Gallium-68-prostate-specific membrane antigen ( Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.镓-68-前列腺特异性膜抗原(Ga-PSMA)正电子发射断层扫描(PET)/计算机断层扫描(CT)可预测中高危前列腺癌根治性前列腺切除术和淋巴结清扫术后的完全生化缓解。
BJU Int. 2019 Jul;124(1):62-68. doi: 10.1111/bju.14506. Epub 2019 Apr 7.
10
Primary lymph-node staging with Ga-PSMA PET in high-risk prostate cancer: pathologic correlation with extended pelvic lymphadenectomy specimens.高危前列腺癌中 Ga-PSMA PET 进行初级淋巴结分期:与扩大盆腔淋巴结清扫标本的病理相关性。
Urol Oncol. 2021 Aug;39(8):494.e1-494.e6. doi: 10.1016/j.urolonc.2020.10.074. Epub 2020 Nov 19.

本文引用的文献

1
2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review.2022 年前列腺癌流行病学和风险因素的更新:系统评价。
Eur Urol. 2023 Aug;84(2):191-206. doi: 10.1016/j.eururo.2023.04.021. Epub 2023 May 16.
2
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
Using PSMA imaging for prognostication in localized and advanced prostate cancer.利用前列腺特异性膜抗原(PSMA)成像对局限性和晚期前列腺癌进行预后评估。
Nat Rev Urol. 2023 Jan;20(1):23-47. doi: 10.1038/s41585-022-00670-6. Epub 2022 Dec 6.
4
Incorporating Prostate-specific Membrane Antigen Positron Emission Tomography in Management Decisions for Men with Newly Diagnosed or Biochemically Recurrent Prostate Cancer.将前列腺特异性膜抗原正电子发射断层扫描纳入新诊断或生化复发前列腺癌男性管理决策中。
Eur Urol. 2023 Jun;83(6):521-533. doi: 10.1016/j.eururo.2022.10.024. Epub 2022 Nov 18.
5
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer.PSMA PET 和 WB MRI 作为前列腺癌下一代成像工具的未来。
Nat Rev Urol. 2022 Aug;19(8):475-493. doi: 10.1038/s41585-022-00618-w. Epub 2022 Jul 4.
6
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials.靶向前列腺癌中的信号通路:机制与临床试验。
Signal Transduct Target Ther. 2022 Jun 24;7(1):198. doi: 10.1038/s41392-022-01042-7.
7
Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement.镓-PSMA PET 在前列腺癌中的应用:观察者一致性的系统评价和荟萃分析。
Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1021-1029. doi: 10.1007/s00259-021-05616-5. Epub 2021 Nov 12.
8
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.68Ga-PSMA-11 PET 对根治性前列腺切除术和盆腔淋巴结清扫术前盆腔淋巴结转移检测的诊断准确性:一项多中心前瞻性 3 期影像学试验。
JAMA Oncol. 2021 Nov 1;7(11):1635-1642. doi: 10.1001/jamaoncol.2021.3771.
9
Imaging of Prostate Cancer.前列腺癌影像学。
Dtsch Arztebl Int. 2021 Oct 22;118(42):713-719. doi: 10.3238/arztebl.m2021.0309.
10
Novel approaches to target the microenvironment of bone metastasis.针对骨转移微环境的新方法。
Nat Rev Clin Oncol. 2021 Aug;18(8):488-505. doi: 10.1038/s41571-021-00499-9. Epub 2021 Apr 19.